Ecopetrol S.A. (E1CO34)
B3 Stock Exchange · Brazil · prices in BRL · close of 27 Oct 2026
Key indicators
| Last close | BRL 46.05 |
|---|---|
| 52-week range | 24.32 – 49.00 |
| Return, 1 month / 3 months | +6.9% / +14.1% |
| Return, 1 year / 3 years | +94.0% / +135.8% |
| Trend | Uptrend |
| RSI (14) | 57 |
| Volatility (1 year) | 44.7% |
| Worst drawdown (1 year) | -20.8% |
| Average daily value traded | 0.07M BRL |
| Dividend yield | 0.0% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Ecopetrol is an integrated oil and gas company owned mainly by the Colombian state and based in Bogota. It explores for and produces crude oil and natural gas, operates refineries that turn crude into fuels and petrochemicals, and transports hydrocarbons through pipelines. Its products reach industrial customers, distributors and motorists through a network of service stations, and it also has operations in other parts of the Americas.
Ecopetrol S.A. is represented on the B3 Stock Exchange in Brazil by a Brazilian depositary receipt (BDR) under the code E1CO34, with its price quoted in Brazilian reais (BRL). Our dividend records, which start in 2019, show payments in 6 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Ecopetrol S.A. (E1CO34) trades on the B3 Stock Exchange in Brazil. It last closed at BRL 46.05 on 27 October 2026.
Its price-based Market X-Ray is 66 out of 100 (a fair price profile), ranking 253 of 1,455 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 94.0% and over the last three months it rose 14.1%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on B3 Stock Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 83 · Strong | Trading above its long-term averages and near its highs. | |
| Above 200-day average | 21.6% | ||
| From 52-week high | -5.8% | ||
| Momentum | 85 · Strong | Rising faster than most stocks on this exchange. | |
| 3-month return | 14.1% | ||
| 6-month return | 37.0% | ||
| 12-month return, skipping the last month | 81.6% | ||
| Stability (higher is calmer) | 56 · Fair | Typical risk for this exchange. | |
| Volatility, 1 year (lower is calmer) | 44.7% | ||
| Worst drawdown, 1 year (smaller is calmer) | -20.8% | ||
| Liquidity | 56 · Fair | Moderate trading activity. | |
| Average daily value traded | 0.07M BRL | ||
| Zero-volume days | 0.0% | ||
| Income | 18 · Weak | Dividend is small or irregular. | |
| Dividend yield | 0.0% | ||
| Years with dividends | 5 |
Strengths
- Trend: Trading above its long-term averages and near its highs.
- Momentum: Rising faster than most stocks on this exchange.
Weak spots
- Income: Dividend is small or irregular.
Returns
| 1 week | +3.8% |
|---|---|
| 1 month | +6.9% |
| 3 months | +14.1% |
| 6 months | +37.0% |
| 1 year | +94.0% |
| 3 years | +135.8% |
| 5 years | +127.0% |
Signals
| 50-day / 200-day average | 44.19 / 37.88 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 1.90 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 28 Apr 2026 | COP 1.5899 |
| 25 Jun 2025 | COP 1.5120 |
| 25 Apr 2025 | COP 1.4503 |
| 2 Apr 2025 | COP 1.4190 |
| 24 Jun 2024 | COP 2.0600 |
| 4 Apr 2024 | COP 2.0845 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on B3 Stock Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.